TY - JOUR
T1 - Clinical studies of FK037 on complicated urinary tract infection
AU - Suzuki, Keizo
AU - Horiba, Masaki
AU - Katoh, Shinobu
AU - Yonezu, Masahiro
AU - Ishikawa, Kiyohito
AU - Naide, Yorio
AU - Yanaoka, Masanori
AU - Ando, Shinichi
PY - 1994
Y1 - 1994
N2 - FK037, a new injectable cephem antibiotic, was administered in the treatment of 14 complicated urinary tract infections. The drug was given at doses of 0.25~1.0g b. i. d. by intravenous drip infusion for 5 days. The clinical efficacy was evaluated as excellent or moderate in 11 cases out of 13, 85% by the Japanese UTI criteria. Bacteriologically, 20 strains out of 22, 91% were eradicated after the therapy. Against strains of Pseudomonas aeruginosa, the response was 1 out of 3 strains. In the safety profile, no side events or abnormal laboratory findings were caused by FK037.
AB - FK037, a new injectable cephem antibiotic, was administered in the treatment of 14 complicated urinary tract infections. The drug was given at doses of 0.25~1.0g b. i. d. by intravenous drip infusion for 5 days. The clinical efficacy was evaluated as excellent or moderate in 11 cases out of 13, 85% by the Japanese UTI criteria. Bacteriologically, 20 strains out of 22, 91% were eradicated after the therapy. Against strains of Pseudomonas aeruginosa, the response was 1 out of 3 strains. In the safety profile, no side events or abnormal laboratory findings were caused by FK037.
UR - http://www.scopus.com/inward/record.url?scp=0028116045&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028116045&partnerID=8YFLogxK
U2 - 10.11250/chemotherapy1953.42.Supplement3_448
DO - 10.11250/chemotherapy1953.42.Supplement3_448
M3 - Article
AN - SCOPUS:0028116045
SN - 0009-3165
VL - 42
SP - 448
EP - 453
JO - CHEMOTHERAPY
JF - CHEMOTHERAPY
ER -
